1. Home
  2. CDNA vs ICHR Comparison

CDNA vs ICHR Comparison

Compare CDNA & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • ICHR
  • Stock Information
  • Founded
  • CDNA 1998
  • ICHR 1999
  • Country
  • CDNA United States
  • ICHR United States
  • Employees
  • CDNA N/A
  • ICHR N/A
  • Industry
  • CDNA Medical Specialities
  • ICHR Semiconductors
  • Sector
  • CDNA Health Care
  • ICHR Technology
  • Exchange
  • CDNA Nasdaq
  • ICHR Nasdaq
  • Market Cap
  • CDNA 712.2M
  • ICHR 581.2M
  • IPO Year
  • CDNA 2014
  • ICHR 2016
  • Fundamental
  • Price
  • CDNA $13.53
  • ICHR $16.87
  • Analyst Decision
  • CDNA Buy
  • ICHR Strong Buy
  • Analyst Count
  • CDNA 8
  • ICHR 6
  • Target Price
  • CDNA $26.86
  • ICHR $29.80
  • AVG Volume (30 Days)
  • CDNA 1.5M
  • ICHR 737.5K
  • Earning Date
  • CDNA 11-03-2025
  • ICHR 11-03-2025
  • Dividend Yield
  • CDNA N/A
  • ICHR N/A
  • EPS Growth
  • CDNA N/A
  • ICHR N/A
  • EPS
  • CDNA 1.00
  • ICHR N/A
  • Revenue
  • CDNA $340,826,000.00
  • ICHR $929,180,000.00
  • Revenue This Year
  • CDNA $13.02
  • ICHR $14.64
  • Revenue Next Year
  • CDNA $12.85
  • ICHR $5.82
  • P/E Ratio
  • CDNA $13.56
  • ICHR N/A
  • Revenue Growth
  • CDNA 14.72
  • ICHR 15.45
  • 52 Week Low
  • CDNA $10.96
  • ICHR $13.12
  • 52 Week High
  • CDNA $32.97
  • ICHR $36.48
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 52.36
  • ICHR 45.44
  • Support Level
  • CDNA $13.12
  • ICHR $16.28
  • Resistance Level
  • CDNA $13.80
  • ICHR $17.82
  • Average True Range (ATR)
  • CDNA 0.67
  • ICHR 0.72
  • MACD
  • CDNA 0.16
  • ICHR 0.09
  • Stochastic Oscillator
  • CDNA 63.39
  • ICHR 48.70

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

Share on Social Networks: